Factors Associated with the Selection of Mutations Conferring Resistance to Protease Inhibitors (PIs) in PI-Experienced Patients Displaying Treatment Failure on Darunavir

The objective of this study was to characterize the mutations selected by darunavir (DRV) use in protease inhibitor (PI)-experienced patients and the associated factors. We analyzed treatment failure in 54 PI-experienced human immunodeficiency virus (HIV)-infected patients on a DRV- and ritonavir-co...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Lambert-Niclot, Sidonie, Flandre, Philippe, Canestri, Ana, Peytavin, Gilles, Blanc, Christine, Agher, Rachid, Soulié, Cathia, Wirden, Marc, Katlama, Christine, Calvez, Vincent, Marcelin, Anne-Geneviève
Format: Artigo
Jezik:Inglês
Izdano: American Society for Microbiology (ASM) 2008
Teme:
Antiviral Agents
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2224714/
https://ncbi.nlm.nih.gov/pubmed/18039922
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00909-07
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items